Stem cells are defined by two fundamental properties: self-renewal, the ability to undergo unlimited symmetric or asymmetric divisions while maintaining an undifferentiated state, and potency, the capacity to differentiate into specialized cell types. These properties make stem cells a cornerstone of developmental biology and a promising tool for regenerative medicine, where they offer the potential to repair or replace damaged tissues and organs.
Types of Stem Cells
Stem cells are classified by their developmental origin and differentiation potential. Embryonic stem cells (ESCs), derived from the inner cell mass of the blastocyst, are pluripotent, meaning they can generate all cell types of the three germ layers (ectoderm, mesoderm, endoderm) but not extraembryonic tissues. Adult stem cells, also called somatic or tissue-specific stem cells, are multipotent and reside in most tissues, where they maintain and repair the tissue throughout life. Well-characterized adult stem cells include hematopoietic stem cells in bone marrow that generate all blood cell lineages, mesenchymal stem cells in bone marrow and adipose tissue that differentiate into bone, cartilage, and fat cells, neural stem cells in the subventricular zone and hippocampus, and intestinal stem cells at the base of crypts. Induced pluripotent stem cells (iPSCs) are generated by reprogramming somatic cells through forced expression of transcription factors Oct4, Sox2, Klf4, and c-Myc (Yamanaka factors), yielding cells with ESC-like properties that can be derived from any individual, enabling patient-specific disease modeling and personalized medicine approaches. Fetal stem cells, isolated from umbilical cord blood, amniotic fluid, and placenta, have intermediate properties between embryonic and adult stem cells.
Stem Cell Niche
Stem cells reside in specialized microenvironments called niches that provide extrinsic signals regulating self-renewal, quiescence, and differentiation. The niche includes supporting stromal cells, extracellular matrix components, soluble factors, and physical cues such as oxygen tension and mechanical stiffness. The hematopoietic stem cell niche in bone marrow includes osteoblasts, perivascular mesenchymal cells, and sinusoidal endothelial cells that produce stem cell factor (SCF), CXCL12, thrombopoietin, and other factors maintaining stem cell quiescence and retention. The intestinal stem cell niche at the crypt base provides Wnt, Notch, and EGF signals from Paneth cells and stromal cells, with Wnt signaling being essential for stem cell maintenance. The bulge region of the hair follicle contains hair follicle stem cells that are activated by signals from the dermal papilla during the hair cycle. Disruption of niche signaling can lead to stem cell depletion or uncontrolled proliferation, contributing to aging and cancer.
Self-Renewal and Differentiation Pathways
Stem cell fate decisions are governed by conserved signaling pathways that balance self-renewal versus differentiation. The Wnt/β-catenin pathway promotes self-renewal in intestinal stem cells, embryonic stem cells, and some adult stem cells, with β-catenin translocating to the nucleus and activating target genes including Myc and Cyclin D1. The Notch pathway, mediated by cell-cell contact between Delta/Jagged ligands and Notch receptors, maintains stem cell identity in the intestine, nervous system, and muscle. The Hedgehog pathway, activated by Sonic, Indian, and Desert hedgehog ligands, regulates stem cell proliferation in the cerebellum, skin, and hematopoietic system. The PI3K/Akt/mTOR pathway integrates growth factor signals to promote proliferation and protein synthesis. Leukemia inhibitory factor (LIF) and BMP signaling maintain mouse ESC pluripotency through STAT3 and Smad activation, while FGF and TGF-β/Activin/Nodal pathways sustain human ESC self-renewal.
Regenerative Medicine Applications
Regenerative medicine aims to restore tissue function by replacing or regenerating damaged cells, tissues, or organs using stem cells, engineered scaffolds, and growth factors. Hematopoietic stem cell transplantation (bone marrow transplantation) is the most widely used stem cell therapy, employed for over 50 years to treat leukemias, lymphomas, and genetic blood disorders, with over one million transplants performed worldwide. Mesenchymal stem cells are being investigated for tissue repair in osteoarthritis (cartilage regeneration), myocardial infarction (cardiac repair after heart attack), graft-versus-host disease (immunomodulation), and spinal cord injury. Limbal stem cell transplantation restores the corneal epithelium in patients with corneal damage. iPSC-derived dopamine neurons are being tested in clinical trials for Parkinson disease, and iPSC-derived retinal pigment epithelial cells for age-related macular degeneration. Clinical translation faces challenges including tumorigenic risk (particularly with ESCs and iPSCs), immune rejection, heterogeneity of differentiated cell populations, and scalable manufacturing under good manufacturing practice (GMP) conditions.
Disease Modeling and Drug Discovery
Patient-derived iPSCs can be differentiated into disease-relevant cell types to model genetic disorders in vitro, recapitulating disease phenotypes in culture. Disease modeling with iPSCs has been established for neurodegenerative diseases including Parkinson disease, Alzheimer disease, amyotrophic lateral sclerosis (ALS), and Huntington disease, where patient neurons show characteristic protein aggregation, mitochondrial dysfunction, and electrophysiological abnormalities. Cardiac disease models including long QT syndrome, hypertrophic cardiomyopathy, and Duchenne muscular dystrophy-derived cardiomyocytes recapitulate arrhythmias and contractile defects. iPSC-derived liver cells model metabolic diseases and enable hepatotoxicity screening. Organoids, three-dimensional self-organizing tissue cultures derived from stem cells, recapitulate tissue architecture and function more faithfully than monolayer cultures, enabling studies of organ development, infectious diseases such as Zika virus-induced microcephaly, and drug response in a patient-specific context.
Ethical Considerations in Stem Cell Research
Stem cell research, particularly involving human embryos, raises ethical concerns that vary across jurisdictions. The derivation of ESCs from human embryos requires destruction of the embryo, which some consider morally problematic, leading to policies ranging from prohibition to regulated permission. The development of iPSCs bypasses the embryo destruction issue and has broadened the moral consensus supporting stem cell research, though iPSCs raise other concerns including the potential for germline modification and the creation of human-animal chimeras for research. Mitochondrial replacement therapy, which uses stem cell techniques to prevent transmission of mitochondrial disease, has been legalized in some countries but remains controversial owing to concerns about germline genome modification and the creation of three-parent embryos. Informed consent, donor compensation, and equitable access to stem cell therapies are ongoing ethical and policy challenges. Unproven stem cell treatments marketed directly to patients pose safety risks and undermine public trust in legitimate stem cell research.
